» Articles » PMID: 1375278

Broad Cross-reactivity with Marked Fine Specificity in the Cytotoxic T Cell Response to Flaviviruses

Overview
Journal J Gen Virol
Specialty Microbiology
Date 1992 May 1
PMID 1375278
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Cytotoxic T (Tc) cells were generated in mice of five H-2 haplotypes against the flaviviruses Kunjin and West Nile (WNV). A panel of recombinant vaccinia viruses which between them expressed cDNA of the entire Kunjin virus genome were used to infect targets. Anti-Kunjin virus responses to determinants derived from non-structural proteins, especially NS3, NS4A and NS4B, were dominant in most mouse strains; usually only one class I major histocompatibility complex (MHC) restriction element was involved. WNV-immune Tc cells showed similar but not identical patterns of antigen recognition to Kunjin virus-immune Tc cells. The extent to which WNV-immune Tc cells recognized Kunjin virus-encoded determinants varied considerably between mice of different MHC haplotypes.

Citing Articles

The Japanese Encephalitis Antigenic Complex Viruses: From Structure to Immunity.

Khare B, Kuhn R Viruses. 2022; 14(10).

PMID: 36298768 PMC: 9607441. DOI: 10.3390/v14102213.


Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63.

Saletti G, Gerlach T, Jansen J, Molle A, Elbahesh H, Ludlow M Sci Rep. 2020; 10(1):21447.

PMID: 33293664 PMC: 7722724. DOI: 10.1038/s41598-020-78506-9.


Cross-Reactive Immunity Among Flaviviruses.

Rathore A, St John A Front Immunol. 2020; 11:334.

PMID: 32174923 PMC: 7054434. DOI: 10.3389/fimmu.2020.00334.


Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Mathew A, Townsley E, Ennis F Future Microbiol. 2014; 9(3):411-25.

PMID: 24762312 PMC: 4113002. DOI: 10.2217/fmb.13.171.


Immune responses to an attenuated West Nile virus NS4B-P38G mutant strain.

Welte T, Xie G, Wicker J, Whiteman M, Li L, Rachamallu A Vaccine. 2011; 29(29-30):4853-61.

PMID: 21549792 PMC: 3114109. DOI: 10.1016/j.vaccine.2011.04.057.